CTX-10726

· Compass Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CTX-10726, covering 2026-04-09 to 2026-04-09. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Study of the Safety and Tolerability of CTX-10726 [Phase 1]